Références
SHIVANANDA S., LENNARD-JONES J., LOGAN R.et al. —Incidence of inflammatory bowel disease across Europe: is there a difference between north and South? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).Gut, 1996,39, 690–697.
FELLOWS I.W., FREEMAN J.G., HOLMES G.K.— Crohn's disease in the city of Derby, 1951–1985.Gut, 1990,31, 1262–1265.
MUNKHOLM P., LANGHOLZ E., NIELSEN O.H.et al.— Incidence and prevalence of Crohn's disease in the country of Copenhagen, 1962–87: a sixfold increase in incidence.Scand. J. Gastroenterol., 1992,27, 609–614.
LOFTUS E.V., SILVERSTEIN M.D., SANDBORN W.J.et al. —Crohn's disease in Olmsted County, Minnesota, 1940–93: incidence, prevalence and survival.Gastroenterology, 1998,114, 1161–1168.
PALLI D., TRALLORI G., TARANTINO O.et al.—General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence study.Gut, 1998,42, 175–179.
EADEN J.A., MAYBERRY J.F.—Colorectal cancer complicating ulcerative colitis: a review.Am. J. Gastroenterol., 2000,95, 2710–2719.
FRIEDMAN S., RUBIN P.H., BODIAN C., GOLDSTEIN E., HARPAZ N., PRESENT D.H.—Screening and surveillance colonoscopy in chronic Crohn's colitis.Gastroenterology, 2001,120, 820–826.
American society for gastrointestinal endoscopy. Guidelines for colorectal cancer screening and surveillance.Gastrointest. Endosc., 2000,51, 777–782.
BERNSTEIN C.N., BLANCHARD J.F., KLIEWER E., WAJDA A.—Cancer risk in patients with inflammatory bowel disease: a population-based study.Cancer, 2001,91, 854–862.
BANSAL P., SONNENBERG A.—Risk factors of colorectal cancer in inflammatory bowel disease.Am. J. Gastroenterol., 1996,91, 44–48.
DE DOMBAL F.T., WATTS J.M., WATKINSON G.et al.— Local complications of ulcerative colitis: stricture, pseudopolyposis and carcinoma of colon and rectum.Br. Med. J., 1966,1, 1442–1447.
EDWARDS F.C., TRUELOVE S.C.—The course and prognosis of ulcerative colitis.Gut, 1963,4, 299–315.
GREENSTEIN A.J., SACHAR D.B., SMITH H.et al.— Cancer in universal and left-sided ulcerative colitis: factors determining risk.Gastroenterology, 1979,77, 290–294.
KATZKA I., BRODY R.S., MORRIS E.et al.—Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice.Gastroenterology, 1983,85, 22–29.
LENNARD-JONES J.E., MORSON B.C., RITCHIE J.K.et al. —Cancer surveillance in ulcerative colitis: experience over 15 years.Lancet, 1983,2, 149–152.
MIR-MADJLESSI S.H., FARMER R.G. EASLEY K.A.et al. —Colorectal and extracolonic malignancy in ulcerative colitis.Cancer, 1986,58, 1569–1574.
PRIOR P., GYDE S.N., MACARTNEY J.C.et al.—Cancer in ulcerative colitis.Gut, 1982,23, 490–497.
LANGHOLZ E., MUNKOLM P., DAVIDSEN M.et al.— Colorectal cancer risk and mortality in patients with ulcerative colitis.Gastroenterology, 1992,103, 1444–1451.
LENNARD-JONES J.E., MELVILLE D.M., MORSON B.et al. —Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years.Gut, 1990,31, 800–806.
EADEN J.A., ABRAMS K.R., MAYBERRY J.F.—The true risk of colorectal cancer in ulcerative colitis: A meta-analysis.Gut, 1999,44 (suppl. 1), T163 (abstract).
EKBOM A., HELMICK C., ZACK M.et al.—Ulcerative colitis and colorectal cancer. A population-based study.N. Engl. J. Med., 1990,323, 1228–1233.
KARLEN P., LOFBERG R., BRÖSTROM O., LEIJONMARCK C.E., HELLERS G., PERSSON P.G.—Increased risk of cancer in ulcerative colitis: a population-based cohort study.Am. J. Gastroenterol., 1999,94, 1047–1052.
RANSOHOFF D.F.—Colon cancer in ulcerative colitis.Gastroenterology, 1988,94, 1089–1091.
PROVENZALE D., KOWDLEY K.V., ARORA S.et al.— Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis.Gastroenterology, 1995,109, 1188–1196.
GYDE S.N., PRIOR P., ALLAN R.N.et al.—Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.Gut, 1988,29, 206–217.
GREENSTEIN A.J., SACHAR D.B., SMITH H.et al.—Patterns of neoplasia in Crohn's disease and ulcerative colitis.Cancer, 1980,46, 403–407.
AADLAND E., SCHRUMPF E., FAUSA O.et al.—Primary sclerosing cholangitis: a long-term follow-up study.Scand. J. Gastroenterol., 1987,22, 655–664.
BRENTNALL T.A., HAGGITT R.C., RABINOVITCH P.S.et al.—Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.Gastroenterology, 1996,110, 331–338.
BROOME U., LINDBERG G., LOFBERG R.—Primary sclerosing cholangitis in ulcerative colitis. A risk factor for the development of dysplasia and DNA aneuploidy?Gastroenterology, 1992,102, 1877–1880.
KORNFELD D., EKBOM A., LHRE T.—Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study.Gut, 1997,41, 522–525.
SHETTY K., RYBICKI L., BRZEZINSKI A., CAREY W.D., LASHNER B.A.—The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.Am. J. Gastroenterol., 1999,94, 1643–1649.
BROOME U., LOFBERG R., VERESS B.et al.—Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.Hepatology, 1995,22, 1404–1408.
NUAKO K.W., AHLIQUIST D.A., MAHONEY D.W.et al. —Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study.Gastroenterology, 1998,115, 1079–1083.
ASKLING J., DICKMAN P.W., KARLEN P., BRÖSTROM O., LAPIDUS A., LOFBERG R., EKBOM A.—Family history as a risk factor for colorectal cancer in inflammatory bowel disease.Gastroenterology, 2001,120, 1356–1362.
ASKLING J., DICKMAN P.W., KARLEN P., BRÖSTROM O., LAPIDUS A., LOFBERG R., EKBOM A.— Colorectal cancer rates among first degree relatives of patients with inflammatory bowel disease: a population-based cohort study.Lancet, 2001,357, 262–266.
MUNKHOLM P., LANGHOLZ E., DAVIDSEN M., BINDER V. —Intestinal cancer risk and mortality in patients with Crohn's disease.Gastroenterology, 1993,105, 1716–1723.
PERSSON P.G., KARLEN P., BERNELL O., LEIJONMARK C.E., BROSTRÖM O., AHLBOM A., HELLERS.— Crohn's disease and cancer: a population-based cohort study.G. Gastroenterology, 1994,107, 1675–1679.
EKBOM A., HELMICK C., ZACK M.et al.—Increased risk of large-bowel cancer in Crohn's disease with colonic involvement.Lancet, 1990,336, 357–359.
GILLEN C.D., ANDREWS H.A., PRIOR P.et al.—Crohn's disease and colorectal cancer.Gut, 1994,35, 651–655
FARRELL R.J., ANG Y., KILEEN P., O'BRIAIN D.S., KELLEHER D., KEELING P.W.et al.—Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.Gut, 2000,47, 514–519.
PALLI D., TRALLORI G., BAGNOLI S., SAIEVA C., TARANTINO O., CEROTI M.et al.—Hodgkin's disease risk is increased in patients with ulcerative colitis.Gastroenterology, 2000,119, 647–653.
RIDDELL R.H.—Screening strategies in gastrointestinal cancer.Scand. J. Gastroenterol., 1990,175 (suppl.), 177–184.
CONNELL W.R., LENNARD-JONES J.E., WILLIAMS C.B.et al.—Pactors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.Gastroenterology, 1994,107, 934–944.
BERNSTEIN C.N., SHANAHAN F., WEINSTEIN W.M.— Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?Lancet, 1994,343, 71–74.
CHOI P.M.—Predominance of rectosigmoid neoplasia in ulcerative colitis and its implication on cancer surveillance.Gastroenterology, 1993,104, 666–667.
LASHNER B.A., HANAUER S.B., SILVERSTEIN M.D.— Optimal timing of colonoscopy to screen for cancer in ulcerative colitis.Ann. Intern. Med., 1988,108, 274–278.
HANAUER S.B.—Surveying surveillance: are gastroentero-logists consistently inconsistent, inconsistently consistent, or poorly educated?Gastrointest. Endosc., 2000,51, 240–242.
AXON A.T.—Cancer surveillance in ulcerative colitis-a time for reappraisal.Gut, 1994,35, 587–589.
RUBIN C.E., HAGGITT R.C., BURMER G.C.et al.—DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis.Gastroenterology, 1992,103, 1611–1620.
CONNELL W.R., TALBOTI C., HARPAZ N.et al.—Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.Gut, 1994,35, 1419–1423.
WOOLRICH A.J., DASILVA M.D., KORELITZ B.I.—Surveillance in the routine management of ulcerative colitis: the predictive value of low grade dysplasia.Gastroenterology, 1992,103, 431–438.
ODZE R.D.—Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological and molecular review.Am. J. Gastroenterol., 1999,94, 1746–1750.
LYNCH D.A., LOBO A.J., SOBALA G.M.et al.—Failure of colonoscopic surveillance in ulcerative colitis.Gut, 1993,34, 1075–1080.
CHOI P.M., NUGENT F.W., SCHOETZ D.J.et al.—Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.Gastroenterology, 1993,105, 418–424.
KARLEN P., KORNFELD D., BROSTROM O., LOFBERG R., PERSSON P.G., EKBOM A. Is colonic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study.Gut, 1998,42, 711–714.
RIDDELL R.H., GOLDMAN H., RANSOHOFF D.F.et al. —Dysplasia in inflammatory bowel disease: standardised classification with provisional clinical applications.Hum. Pathol., 1983,14, 931–966.
BERNSTEIN C.N., WEINSTEIN W.M., LEVINE D.S., SHANAHAN F.—Physician's perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis.Am. J. Gastroenterol., 1995,90, 2106–2114.
EENGELSGJERD M., FARRAYE F.A., ODZE R.D.—Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.Gastroenterology, 1999,117, 1288–1294.
RUBIN P.H., FRIEDMAN S., HARPAZ N., GOLDSTEIN E., WEISER J., SCHILLER J., WAYE J.D., PRESENT D.H. —Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps.Gastroenterology, 1999,117, 1295–1300.
DELCO F., SONNENBERG A.—A decision analysis of surveillance for colorectal cancer in ulcerative colitis.Gut, 2000,46, 500–506.
PROVENZALE D., WONG J.B., ONKEN J.E., LIPSCOMB J. —Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis.Am. J. Gastroenterol., 1998,93, 872–800.
EADEN J.A., WARD B.A., MAYBERRY J.F.—How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance.Gastrointest. Endosc., 2000,51, 123–128.
Author information
Authors and Affiliations
About this article
Cite this article
Barthet, M. Maladies inflammatoires chroniques de l'intestin. Acta Endosc 31 (Suppl 4), 576–582 (2001). https://doi.org/10.1007/BF03018006
Issue Date:
DOI: https://doi.org/10.1007/BF03018006